当前位置:首页 - 行情中心 - 康弘药业(002773) - 财务分析

康弘药业

(002773)

  

流通市值:137.41亿  总市值:184.42亿
流通股本:6.85亿   总股本:9.20亿

康弘药业(002773)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润9.65亿元,每股收益1.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益843458.04万元,未分配利润500530.98万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产921282.91万元,负债77824.87万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入3,411,293,193.612,294,131,650.051,092,784,087.913,957,459,641.68
营业总成本2,311,766,338.661,512,181,562.51658,811,628.422,807,068,148.65
营业利润1,148,722,614.3820,529,673.13446,538,255.421,261,067,651.4
利润总额1,138,170,500.15817,297,898.16445,981,688.941,233,916,973.28
净利润964,889,830.03686,536,094.24371,475,098.051,031,123,914.21
其他综合收益-148,087.22-470,338.38-586,682.08-291,301.28
综合收益总额964,741,742.81686,065,755.86370,888,415.971,030,832,612.93
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计6,203,269,721.255,814,478,777.85,696,165,936.085,305,607,081.17
非流动资产合计3,009,559,372.193,061,094,035.083,137,182,422.013,224,073,829.53
资产总计9,212,829,093.448,875,572,812.888,833,348,358.098,529,680,910.7
流动负债合计735,492,143.57670,144,856.32594,495,406.58654,431,822.37
非流动负债合计42,756,564.4949,464,925.9255,481,924.5463,332,040.04
负债合计778,248,708.06719,609,782.24649,977,331.12717,763,862.41
归属于母公司股东权益合计8,435,514,491.738,153,759,334.688,177,529,760.327,804,029,406.63
股东权益合计8,434,580,385.388,155,963,030.648,183,371,026.977,811,917,048.29
负债和股东权益合计9,212,829,093.448,875,572,812.888,833,348,358.098,529,680,910.7
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计3,684,526,280.032,436,497,995.921,173,282,168.714,352,805,943.42
经营活动现金流出小计2,430,058,668.411,631,480,465.41767,346,299.113,134,394,814.67
经营活动产生的现金流量净额1,254,467,611.62805,017,530.51405,935,869.61,218,411,128.75
投资活动现金流入小计2,132,043,970.541,970,795,550.06166,6884,722,930,488.72
投资活动现金流出小计4,448,980,731.724,146,710,709.232,003,173,073.64,716,314,269.5
投资活动产生的现金流量净额-2,316,936,761.18-2,175,915,159.17-2,003,006,385.66,616,219.22
筹资活动现金流入小计6,747,149.4--9,412,344
筹资活动现金流出小计349,945,523.88349,791,692.88107,240139,910,029.44
筹资活动产生的现金流量净额-343,198,374.48-349,791,692.88-107,240-130,497,685.44
汇率变动对现金及现金等价物的影响-746,257.11-303,605.12-251,158.87-211,713.87
现金及现金等价物净增加额-1,406,413,781.15-1,720,992,926.66-1,597,428,914.871,094,317,948.66
期末现金及现金等价物余额3,263,580,439.452,949,001,293.943,072,565,305.734,669,994,220.6
最新报告期:2024-10-19
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
西南证券杜向阳1.311.501.672024-10-19
TOP↑